Three Therapeutic Schemes for Cerebral Arteriosclerosis:Cost-Effectiveness Analysis / 中国药房

0.05);the costs were 459.00 yuan,481.68 yuan and 789.48 yuan,respectively,showing significant differences between Group A and Group C or between Group B and Group C(P0.05).CONCLUSION: Group A is preferable in terms of cost-effectiveness,while there was no significant difference between Group A and Group B in cost.